Diphen
NDC 82652-021

View NDC Profile UNII Mappings and RxNorm Concepts.

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Diphen is a ANDA-approved product labeled by Remedy Pack Llc. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a product. This product entry covers the primary NDC 82652-021 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.

Primary Identification

NDC Product Code:
82652-021
Proprietary Name:
Diphen
Product Type: [3]
INACTIVATED PRODUCT and EXCLUDED the from NDC Directory
Code Navigator:

Labeler & Regulatory Data

Labeler Name: [5]
Labeler Code:
82652
FDA Application Number: [6]
ANDA076134
Marketing Category: [8]
ANDA - A product marketed under an approved Abbreviated New Drug Application.

Marketing Timeline

Start Marketing Date: [9]
05-10-2022
Listing Expiration Date: [11]
12-31-2024
Exclude Flag: [12]
I

Product Characteristics

Color(s):
Alcalak (NDC 82652-023): WHITE (C48325)
I-Prin (NDC 82652-024): BROWN (C48332)
Loradamed (NDC 82652-022): WHITE (C48325)
Cold Relief (NDC 82652-032): WHITE (C48325)
Diphen (NDC 82652-031): PINK (C48328)
Medi-Lyte: WHITE (C48325)
Medi-Meclizine (NDC 82652-030): YELLOW (C48330)
Extra Strength APAP (NDC 82652-025): WHITE (C48325)
Diotame (NDC 82652-026): PINK (C48328)
Shape:
Alcalak (NDC 82652-023): ROUND (C48348)
I-Prin (NDC 82652-024): ROUND (C48348)
Loradamed (NDC 82652-022): ROUND (C48348)
Cold Relief (NDC 82652-032): ROUND (C48348)
Diphen (NDC 82652-031): CAPSULE (C48336)
Medi-Lyte: ROUND (C48348)
Medi-Meclizine (NDC 82652-030): ROUND (C48348)
Extra Strength APAP (NDC 82652-025): ROUND (C48348)
Diotame (NDC 82652-026): ROUND (C48348)
Size(s):
Alcalak (NDC 82652-023): 11 MM
I-Prin (NDC 82652-024): 10 MM
Loradamed (NDC 82652-022): 6 MM
Cold Relief (NDC 82652-032): 12 MM
Diphen (NDC 82652-031): 11 MM
Medi-Lyte: 9 MM
Medi-Meclizine (NDC 82652-030): 9 MM
Extra Strength APAP (NDC 82652-025): 12 MM
Diotame (NDC 82652-026): 16 MM
Imprint(s):
Alcalak (NDC 82652-023): AZ;036
I-Prin (NDC 82652-024): 44;291
Loradamed (NDC 82652-022): RX;526
Cold Relief (NDC 82652-032): FR;12
Diphen (NDC 82652-031): 048;D
Medi-Meclizine (NDC 82652-030): 44;403
Extra Strength APAP (NDC 82652-025): FR;33
Diotame (NDC 82652-026): RH;046
Score:
Alcalak (NDC 82652-023): 1
I-Prin (NDC 82652-024): 1
Loradamed (NDC 82652-022): 1
Cold Relief (NDC 82652-032): 1
Diphen (NDC 82652-031): 1
Medi-Lyte: 1
Medi-Meclizine (NDC 82652-030): 1
Extra Strength APAP (NDC 82652-025): 1
Diotame (NDC 82652-026): 1
Flavor(s):
Diotame (NDC 82652-026): PEPPERMINT (C73408)

Code Structure Chart

Product Details

What is NDC 82652-021?

The NDC code 82652-021 is assigned by the FDA to the product Diphen. This pharmaceutical product is labeled by Remedy Pack Llc and is currently categorized as listed product. In terms of distribution, this product is available in a single package configuration. The associated package NDC(s) include: 82652-021-01. Beyond standard identification, this entry provides technical data including pharmacologic classes, UNII ingredient references, and RxNorm cross-referencing for healthcare systems.

What are the uses of this product?

Adults and children 2 years and over:clean the affected areaapply a small amount of this product on the area 3 to 4 times dailymay be covered with a sterile bandageChildren under 12 years: consult a doctorChildren under 2 years: consult a doctor clean the affected area apply a small amount of this product (an amount equal to the surface area of the tip of a finger) on the area 1 to 3 times daily may be covered with a sterile bandage Adult and children (2 years and over): apply to affected not more than 3 to 4 times dailyChildren under 2 years: Consult a doctor. Apply only amount needed to the oral mucosa to prevent or relieve pain.children under 2 years of age: do not use do not use more than directedAdults and children: (12 years and older) Chew 2 tablets every 2 or 3 hours as symptoms occur or as directed by a physician. Do not exceed 19 tablets in 24 hours.Children under 12 years: Do not give to children under 12 years of age. Adults and children: (12 years and older) Take 2 tablets with water every 6- 8 hours as needed. Do not take more than 8 tablets in 24 hours.Children under 12 years: Do not give to children under 12 years of age. do not use more than directedto prevent motion sickness, take the first dose one hour before starting activityAdults and children: (12 years and older) 1 to 2 tablets once daily or as directed by a doctor. Do not exceed 2 tablets in 24 hours.Children under 12 years: Do not give to children under 12 years of age. do not take more than directedthe smallest effective dose should be useddo not take longer than 10 days, unless directed by a doctor (see Warnings)Adults and children: (12 years and older) Take 1 tablet every 4 to 6 hours while symptoms persist. If pain or fever does not respond to 1 tablet, 2 tablets may be used. Do not exceed 6 tablets in 24 hours, unless directed by a doctor.Children under 12 years: Do not give to children under 12 years of age. do not use more than directedAdults and children: (12 years and older) Take 1 to 2 caplets every 4 to 6 hours as needed. Do not take more than 12 caplets in 24 hours, or as directed by a doctor.Children under 12 years: Do not give to children under 12 years of age. do not use more than directedAdults and children: (12 years and older) Take 2 tablets every 4 to 6 hours as needed. Do not take more than 8 tablets in 24 hours.Children under 12 years: Do not give this adult strength product to children under 12 years of age; this will provide more than the recommended dose (overdose) and may cause liver damage. Adults and children: (12 years and older) Take 1 tablet daily; not more than 1 tablet in 24 hours.Children under 12 years: Do not give to children under 12 years of age.Consumers with liver or kidney disease: Ask a doctor before using. Adults and children: (12 years and older)take 2 tablets as needed with a full glass of watermay be repeated every hour as neededdo not exceed 20 tablets in 24 hoursChildren under 12 years:Do not give to children under 12 years of age do not use more than directedchew or crush tablets completely before swallowingdo not swallow tablets wholeuse until diarrhea stops but not more than 2 daysdrink plenty of clear fluids to help prevent dehydration, which may accompany diarrheado not exceed 16 tablets in 24 hoursAdults and children: (12 years and older) Chew 2 tablets every 1/2 to 1 hour or 4 tablets every hour as needed.Children under 12 years: Do not give to children under 12 years of age.

Which are the associated UNII Codes?

The UNII codes for the active ingredients in this product are:

  • Pain Relief (NDC 82652-033)
  • Burn (NDC 82652-029)
  • Hydrocortisone (NDC 82652-027)
  • Triple Antibiotic (NDC 82652-028)
  • Alcalak (NDC 82652-023)
  • I-Prin (NDC 82652-024)
  • Loradamed (NDC 82652-022)
  • Cold Relief (NDC 82652-032)
  • Diphen (NDC 82652-031)
  • Medi-Lyte
  • Medi-Meclizine (NDC 82652-030)
  • Extra Strength APAP (NDC 82652-025)
  • Diotame (NDC 82652-026)

Which are the Inactive Ingredients associated UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for this product?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 1012100 - benzalkonium chloride 0.13 % / lidocaine HCl 0.5 % Topical Cream
  • RxCUI: 1012100 - benzalkonium chloride 1.3 MG/ML / lidocaine hydrochloride 5 MG/ML Topical Cream
  • RxCUI: 1012100 - benzalkonium chloride 0.13 % / lidocaine hydrochloride 0.5 % Topical Cream
  • RxCUI: 1043690 - hydrocortisone acetate 1 % Topical Cream
  • RxCUI: 1043690 - hydrocortisone acetate 10 MG/ML Topical Cream

* Please review the full disclaimer at the bottom of this page.

Product & Regulatory Definitions
What is the Labeler Name? Name of Company corresponding to the labeler code segment of the Product NDC.
What is the FDA Application Number? This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
What is the Marketing Category? Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
What is the Start Marketing Date? This is the date that the labeler indicates was the start of its marketing of the drug product.
What is the Listing Expiration Date? This is the date when the listing record will expire if not updated or certified by the product labeler.
What is the NDC Exclude Flag? This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".